UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 15, 2022 4:15 P.M.
Form:
F-1
CIK:
0001611747
Company Name:
BiondVax Pharmaceuticals Ltd.
File Number:
333-267648